Rigel Pharmaceuticals reported $6.8M in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acura Pharmaceuticals ACUR:US 382K 6.52M
Agenus AGEN:US $ 15.72M 18.72M
Amgen AMGN:US $ 916M 5784M
Anika Therapeutics ANIK:US $ 285.79M 1.3M
Applied Genetic Technologies AGTC:US $ 47.03M 4.46M
Arrowhead Research ARWR:US $ 452.27M 79.71M
AstraZeneca AZN:LN 36340M 2928M
Astrazeneca AZN:US $ 36340M 2928M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Bristol Myers Squibb BMY:US $ 31580M 4366M
Celldex Therapeutics CLDX:US $ 398.1M 21.38M
Chemocentryx CCXI:US $ 258.72M 27.4M
Daiichi Sankyo 4568:JP Y 1350872M 19652M
Eli Lilly And LLY:US $ 9330.8M 351.6M
Halozyme Therapeutics HALO:US $ 260.26M 63.3M
Heron Therapeutics HRTX:US $ 23.96M 53.61M
Immunogen IMGN:US $ 306.47M 19.12M
Intrexon XON:US $ 73.84M 33.51M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Ligand Pharmaceuticals LGND:US $ 793.19M 27.97M
Macrogenics MGNX:US $ 178.21M 61.4M
Neurocrine Biosciences NBIX:US $ 1391.1M 17.1M
Pfizer PFE:US $ 82424M 5224M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Rigel Pharmaceuticals RIGL:US $ 6.8M 23.58M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Ultragenyx Pharmaceutical RARE:US $ 796.42M 126.14M
Veracyte VCYT:US $ 1085.19M 11.32M